Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Coronary Heart Disease Complicating Chronic Heart Failure (Syndrome of Qi Deficiency with Blood Stasis): Study Protocol for a Randomized, Placebo-Controlled, Double-Blind and Multi-Centre Phase II Clinical Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Coronary Heart Disease Complicating Chronic Heart Failure (Syndrome of Qi Deficiency with Blood Stasis): Study Protocol for a Randomized, Placebo-Controlled, Double-Blind and Multi-Centre Phase II Clinical Trial

Published:2023-12 Issue: Volume:Volume 16 Page:6177-6188
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

He Xingling,Jiang Yanhui,Li Sijing,Liu Donghua,Li Ziru,Han Xiaowei,Zhang Xiaojiao,Dong Xiaoming,Liu Haohui,Huang Jie,Wang Xiaojing,Long Wenjie,Ni Shihao,Yang Zhongqi,Ye Taochun

Publisher

Informa UK Limited

Subject

General Medicine

Reference23 articles.

1. Heart Failure

2. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary

3. Global burden of heart failure: a comprehensive and updated review of epidemiology

4. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015

5. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring therapeutic targets and molecular mechanisms for treating diabetes mellitus-associated heart failure with Qishen Yiqi dropping pills: A network pharmacology and bioinformatics approach;Medicine;2024-08-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP